Your Cart

Michael Kuo / Hukui Biotechnology Corporation

Michael Kuo / Hukui Biotechnology Corporation
Michael Kuo / Hukui Biotechnology Corporation

Official website:

Ex Tax: $0.00

Michael Kuo

Michael is Co-founder and CEO of Hukui Biotechnology, prior to his biotechnology ventures, Michael had 15 years in early-stage venture capital, angel investment, and 10 years in semiconductor industry. He has extensive interdisciplinary and practical experiences, expertise in incubation, top management recruiting, deal sourcing, due diligences, financial analysis, cost accounting, company evaluating, syndicated funding, strategic alliance, M&A negotiation and IPO tactic planning. 

Michael served as CEO and Initiator of Chiao-Tung University Angel Club in 2012, a tier-one Angel Club in Chinese community. The
Club invested 25+ startups with USD 20 million and the follow-on funding more than USD 150 million. Prior to his entrepreneur and venture capitalist career, he served as electronic engineer in United Microelectronic Corp. (UMC), took in charge of design service function for advanced process customer. UMC is the third semiconductor foundry in the world, with USD 5.2 billion revenue annually. 

Michael is enthusiasm on community service, serves as Executive Director of The University of Chicago Alumni Club of Taiwan, ex-associate director of Chiao-Tung University Alumni Club, and review committee of Innovation and Incubation Center of Tsing-Hwa University. Michael received his MBA from the University of Chicago, Booth School of Business in US, earned his MSEE from National Taiwan University and BSEE from National Chiao-Tung University.

HuKuiBio was established by Mr. John Hsuan, Honorary Vice Chairman of the world-renowned semiconductor company, United Microelectronics Corporation. Chairman Hsuan was involved in the most glorious history of Taiwan’s electronics industry and understood the development of the industry. Chairman Hsuan thinks that corporations must keep up with the times in order to grow rapidly. Looking to the world’s future trends, biotechnology will lead the world into another era with high-speed growth. Emerging technologies have successively arrived in the biotechnology industry in Taiwan, while mainland China is a big market adjacent to Taiwan, and the ageing-population problem in mainland China will result in huge health care expenses.

The purpose of HuKuiBio is to bridge the cross-straits biotechnology and medical industry and to help competitive biotech companies enter China; besides, global dealers can also open up the Chinese market as well as markets of other parts of the world through HuKuiBio. HuKuiTech (Chongqing), a wholly-owned subsidiary, was established in 2016; it mainly engages in the OEM business of medical devices.

Ask Question